Hospital-acquired infections or nosocomial infections can occur in both developed and resource-poor countries. Among hospitalized patients, hospital-acquired infections are some of the major causes of increased morbidity. The most frequent nosocomial infections within the global hospital-acquired control market are urinary tract infections, infections of surgical wounds, and lower respiratory tract infections.
Persistence Market Research’s recently published report on the global HAIs control market provides an extensive assessment of the market, evaluating the growth prospects for a six-year forecast period 2014-2020. It comprises key trends and restraints impacting the overall market growth, recent trends and upcoming opportunities, market segmentation, regional analysis, and key players vying for the leading market position. Starting with an overview of the global HAIs control market, the report further analyzes the factors that positively and negatively influence the demand for HAIs control. It provides deep insights into why HAIs control is expected to gain higher traction in developing markets, and what are the deterring factors that will affect the market growth over the forecast period, 2014-2020. Latest trends and opportunities sections of the report highlight the most valuable data to recognize the most lucrative opportunities for the market growth.
Segmentation of the global market for HAIs control focuses on various HAIs control types. The geographical analysis of the global market examines the market status in three key regions viz. Europe, North America, and Asia. The market report elaborates on why developing markets may witness robust growth and outpace the long-term leader during the forecast period. The next section of the report includes all the leading companies competing in the market for a leading position. Strong presence of global players and established local brands makes the landscape extremely competitive. The report throws light on the growth pattern, revenues, and upcoming opportunities for each of the players.
To deduce the global HAIs control market size, the report considers various aspects based on secondary research. Furthermore, key data points such as region-wise split and market split by type and qualitative inputs from primary respondents have been incorporated to arrive at appropriate market estimates. The forecast presented in the report assesses the total revenue generated and expected revenue contribution in the global HAIs control market.
The report begins with sizing the market in terms of value and volume for the base year, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, gathered data is triangulated via different analysis based on supply side and demand side drivers and other key dynamics of the global HAIs control market. To develop the market forecast, Persistence Market Research has also conducted a factor analysis to understand the impact of various forces/factors on the target market. The report provides forecasts not only in terms of CAGR but also presents a detailed analysis based on key parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities.
Another key feature of this report is an analysis of the global HAIs control market and the corresponding revenue forecast in terms of absolute dollar opportunity, usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global HAIs control market. Further, to understand key segments in terms of their growth and overall global HAIs control market performance, Persistence Market Research has developed a market attractiveness index to help providers identify existing market opportunities in the global HAIs control market.
Hospital-acquired infections (HAIs) is caused by viral, bacterial, and fungal pathogens which can be dangerous for patients as well as for their companions. To avoid these kind of risks of infection in people that are visiting hospitals, the market for HAIs control has emerged to help in reducing the chances of acquiring more infections. The market for HAIs control is witnessing significant and rapid growth owing to a no. of key developments and market drivers. The global market for HAIs control in 2014 registered revenues worth US$ 50,807 Mn, which are projected to raise up to US$ 82,889.4 Mn by 2020 end. Over the forecast period 2014-2020, the global HAIs control market will expand at a CAGR of 8.5%.
Key Market Dynamics
Rising prevalence of HAIs cases, increasing government initiatives expanding awareness about and promoting innovation in anti-HAI technology and procedures, growing demand for improved healthcare facilities, and increasing popularity of cleaning and gas plasma sterilization technology are some of the major drivers contributing to the overall growth of the HAIs control market. However, lack of various healthcare facilities and infrastructure viz. lack of proper supplies, buildings, medical and equipment for communication have hampered the global market for HAIs control. Additionally, lack of awareness and untrained staff in certain developing regions have a negative influence on the growth of global market for HAIs control.
Globally, the prevalence of all the above factors has helped the growth in demand for the HAIs control market. Increasing risk of hospital-acquired infections in hospitals and development of the overall infection control market have formed new market opportunities for the global HAIs control market to grow and improve. Due to lack of training, poor infection control practices in hospitals, increasing geriatric population and people suffering from malnutrition and the consequently decreased levels of immunity, the need for more technical advancements and high focus on improved healthcare facilities has augmented in different regions of the world.
Based on the type, the global HAIs control market is categorized into diagnostic techniques, cleaning and sterilization, and treatment. Among these, the segment of cleaning and sterilization is further categorized into disinfection of linen, instrument sterilization, wide-area sterilization and. Also, the segment of diagnostic techniques is classified into manual testing, automated testing and confirmation testing while the treatment segment is bifurcated as pharmaceutical treatment and environmental treatment. And among these, the pharmaceutical treatment segment is fragmented as viral HAI pharmaceuticals, bacterial HAI pharmaceuticals and fungal HAI pharmaceuticals while the segment of environmental treatment is segmented as air treatment, water treatment and chemical treatment.
Based on geographical region, the global market for HAIs control is segmented into North America, Europe, and Asia. Among these, North America being the largest market dominates the global HAIs market. The U.S. represents the largest market for HAIs control in the North American region. This is due to technical advancements and more focus on improved healthcare facilities in the region. Asia is expected to experience high growth rate in the next five years in HAIs control market. This is due to high prevalence of HAIs in the region and increasing demand for improved healthcare facilities.
Key Market Players
Certain trends observed in the global market for HAIs control include rising popularity of technology of gas plasma sterilization. STERIS Corporation, tailed by Getinge AB is a key player in the global HAIs control market. Several other major players in the global market for HAIs control include Advanced Sterilization Products Division, Hoffmann-La Roche Ltd, Pfizer Inc., and Becton Dickinson & Company, among others.
Some of the major players in the cleaning and sterilization segment in HAIs control market